We use cookies to help us improve the website and your experience using it. You may delete and block all cookies from this site at any time. However, please note this may result in parts of the site no longer working correctly. If you continue without changing your settings we will assume you are happy to receive all cookies on this site.


Work starts on Manchester Royal Infirmary’s new state-of-the-art hybrid theatres


Building work has begun on the construction of a new Hybrid Theatre suite that will transform the care and treatment of patients undergoing minimally invasive procedures, especially in the specialties of Vascular and Cardiac Surgery. The facility is being built in the Elective Treatment Centre of Manchester Royal Infirmary.

Minimally invasive procedures are fast becoming the preferred technique for patients and for surgeons, cardiologists and radiologists and our Trust has many acknowledged leaders in this field. Procedures are performed through tiny incisions rather than one large opening and avoid the need for open surgery meaning a lower chance of infection, a quicker recovery time and less risk of blood loss, pain and scarring for patients.

The two theatres will provide a dedicated facility with state-of-the-art technology, including high definition imaging with a robotic arm for increased mobility, and facilities for traditional surgery all in one place.  They will not only offer better facilities for existing techniques, but will also enable new innovative techniques and treatments to be carried out that are not currently possible.

The hybrid suite is believed to be the first of its kind in the UK and one of only a few existing internationally that offer the same facilities.

The new hybrid suite will be used primarily for vascular and cardiac surgery but will also be used for other specialties such as urology and increasingly complex major trauma.

The new theatres are due for completion April 2014.